全文获取类型
收费全文 | 1521篇 |
免费 | 112篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 70篇 |
妇产科学 | 35篇 |
基础医学 | 209篇 |
口腔科学 | 67篇 |
临床医学 | 83篇 |
内科学 | 335篇 |
皮肤病学 | 38篇 |
神经病学 | 162篇 |
特种医学 | 25篇 |
外科学 | 166篇 |
综合类 | 7篇 |
预防医学 | 119篇 |
眼科学 | 47篇 |
药学 | 108篇 |
中国医学 | 14篇 |
肿瘤学 | 138篇 |
出版年
2023年 | 11篇 |
2022年 | 25篇 |
2021年 | 61篇 |
2020年 | 24篇 |
2019年 | 39篇 |
2018年 | 40篇 |
2017年 | 40篇 |
2016年 | 48篇 |
2015年 | 45篇 |
2014年 | 60篇 |
2013年 | 74篇 |
2012年 | 117篇 |
2011年 | 115篇 |
2010年 | 71篇 |
2009年 | 66篇 |
2008年 | 96篇 |
2007年 | 89篇 |
2006年 | 91篇 |
2005年 | 90篇 |
2004年 | 73篇 |
2003年 | 46篇 |
2002年 | 59篇 |
2001年 | 24篇 |
2000年 | 17篇 |
1999年 | 22篇 |
1998年 | 10篇 |
1997年 | 4篇 |
1996年 | 10篇 |
1995年 | 9篇 |
1994年 | 6篇 |
1993年 | 6篇 |
1992年 | 18篇 |
1991年 | 11篇 |
1990年 | 7篇 |
1989年 | 5篇 |
1988年 | 6篇 |
1987年 | 7篇 |
1986年 | 7篇 |
1985年 | 11篇 |
1984年 | 6篇 |
1983年 | 6篇 |
1982年 | 4篇 |
1976年 | 8篇 |
1975年 | 5篇 |
1973年 | 5篇 |
1972年 | 5篇 |
1970年 | 5篇 |
1967年 | 4篇 |
1966年 | 6篇 |
1965年 | 4篇 |
排序方式: 共有1635条查询结果,搜索用时 31 毫秒
971.
Paulina F. Toledo Gonzalo Crdenas Zoltn Berger Daniela Simian Francisca Araya 《The Turkish journal of gastroenterology》2022,33(8):704
Background:To determine the effect of intramuscular administration of Neostigmine® on the visualization of the pancreatic duct on magnetic resonance cholangiopancreatography in patients with recurrent acute pancreatitis or abdominal pain.Methods:We reviewed patients undergoing magnetic resonance cholangiopancreatography followed by a Neostigmine®-enhanced magnetic resonance cholangiopancreatography. Patients with a history of recurrent acute pancreatitis or abdominal pain who had a magnetic resonance cholangiopancreatography where the pancreatic duct was not entirely seen, were selected to undergo a second magnetic resonance cholangiopancreatography 40 minutes after 0.5 mg Neostigmine®. Images were analyzed by 2 radiologists. The diameter of the pancreatic duct was measured in the head, body, and tail of the pancreas on the baseline images and after Neostigmine®.Results:Ten patients were included, with a median age of 33 years (range 15-61). The maximum diameter of the pancreatic duct increased significantly after Neostigmine® administration in all patients, from 1.84 ± 0.98 to 3.41 ± 1.27 mm in the head, 1.34 ± 0.42 mm to 2.5 ± 0.49 mm in the body and 0.72 ± 0.52 mm to 1.78 ± 0.43 mm in the tail (mean ± SD, P < .0001). Neostigmine® helped to provide better detail of the pancreatic duct anatomy in 4 patients. In 2 patients we confirmed pancreas divisum, in another the Santorini duct was not seen on the baseline images but it was clearly visualized after Neostigmine®, and in the fourth patient, Neostigmine® improved visualization of multiple pancreatic duct stenosis.Conclusion:Neostigmine®-magnetic resonance cholangiopancreatography significantly increases the diameter of the pancreatic duct, allowing an accurate morphological evaluation. It could be a cheap alternative to secretin, which is expensive and hardly available. 相似文献
972.
Hiroaki Shima Giichiro Tsurita Satoshi Wada Yoshihiko Hirohashi Hiroshi Yasui Hiroshi Hayashi Takashi Miyakoshi Kazue Watanabe Aiko Murai Hiroko Asanuma Serina Tokita Terufumi Kubo Munehide Nakatsugawa Takayuki Kanaseki Tomohide Tsukahara Yutaka Nakae Osamu Sugita Yoichi M. Ito Yasunori Ota Yasutoshi Kimura Goro Kutomi Koichi Hirata Toru Mizuguchi Kohzoh Imai Ichiro Takemasa Noriyuki Sato Toshihiko Torigoe 《Cancer science》2019,110(8):2378-2385
The prognosis of advanced pancreatic adenocarcinoma is still extremely poor. This study sought to determine the efficacy of, and immunological response to, peptide vaccination therapy in patients with this disease. In this multicenter randomized phase II study, patients with advanced pancreatic adenocarcinoma after gemcitabine and/or tegafur/gimeracil/oteracil were randomly assigned to 3 groups that each received a 2‐step treatment course. In Step 1, the groups received treatments of: (i) survivin 2B peptide (SVN‐2B) plus interferon‐β (IFNβ); (ii) SVN‐2B only; or (iii) placebo until the patients show progression. In Step 2, all patients who consented to participate received 4 treatments with SVN‐2B plus IFNβ. The primary endpoint was progression‐free survival (PFS) after initiation of Step 1 treatment. Secondary endpoints included immunological effects assessed by analysis of PBMCs after Step 1. Eighty‐three patients were randomly assigned to receive SVN‐2B plus IFNβ (n = 30), SVN‐2B (n = 34), or placebo (n = 19). No significant improvement in PFS was observed. Survivin 2B‐specific CTLs were found to be increased in the SVN‐2B plus IFNβ group by tetramer assay. Among patients who participated in Step 2, those who had received SVN‐2B plus IFNβ in Step 1 showed better overall survival compared with those who had received placebo in Step 1. Patients vaccinated with SVN‐2B plus IFNβ did not have improved PFS, but showed significant immunological reaction after vaccination. Subgroup analysis suggested that a longer SVN‐2B plus IFNβ vaccination protocol might confer survival benefit. (Clinical trial registration number: UMIN 000012146). 相似文献
973.
Bergamo Ana Zilda Nazar Casarin Renato Corrêa Viana do Nascimento Cássio Matsumoto Mírian Aiko Nakane de Carvalho Fabrício Kitazono da Silva Raquel Assed Bezerra da Silva Léa Assed Bezerra Nelson-Filho Paulo 《Odontology / the Society of the Nippon Dental University》2022,110(3):460-466
Odontology - Different types of brackets seem to influence the disruption of the oral microbial environment. Therefore, the aim of this study was to evaluate the influence of self-ligating brackets... 相似文献
974.
975.
976.
977.
Okamoto Keiichiro Kakihara Yoshito Ohkura Naoto Tohma Aiko Washio Ayako Kitamura Chiaki Noiri Yuichiro Yamamura Kensuke Saeki Makio 《Odontology / the Society of the Nippon Dental University》2022,110(2):254-261
Odontology - This study was designed to investigate the effects of Sake Lees extracts (SLE, Sake Kasu) on the functional activity of odontoblastic cells and tooth pulp of the rats. For in vitro... 相似文献
978.
979.
980.
Matsui Yoshiyuki Matsuda Ayumu Maejima Aiko Shinoda Yasuo Nakamura Eijiro Komiyama Motokiyo Fujimoto Hiroyuki 《International journal of clinical oncology / Japan Society of Clinical Oncology》2022,27(6):1093-1100
International Journal of Clinical Oncology - The prognostic factors of retroperitoneal soft tissue sarcoma (STS) have been explored but not yet certain. This study evaluated the prognostic impact... 相似文献